UnitedHealth Group Incorporated $UNH Stock Sold by Rothschild Investment LLC

Rothschild Investment LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 17.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,901 shares of the healthcare conglomerate’s stock after selling 2,635 shares during the quarter. Rothschild Investment LLC’s holdings in UnitedHealth Group were worth $4,736,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently made changes to their positions in UNH. Wellington Altus USA Inc. raised its position in shares of UnitedHealth Group by 97.1% in the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 33 shares in the last quarter. Security National Bank of SO Dak purchased a new position in UnitedHealth Group during the second quarter worth about $29,000. Nvwm LLC boosted its position in shares of UnitedHealth Group by 89.2% during the 3rd quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $26,000 after acquiring an additional 33 shares during the last quarter. Aberdeen Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter worth about $31,000. Finally, Compass Wealth Management LLC purchased a new position in UnitedHealth Group in the 3rd quarter worth approximately $29,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

More UnitedHealth Group News

Investors following UNH have been watching these news items:

  • Positive Sentiment: UnitedHealth appointed longtime healthcare executive Madeline S. Bell to its board, a move that may focus investor attention on governance and long-term capital allocation. Read article
  • Negative Sentiment: Sen. Elizabeth Warren called for breaking up major healthcare conglomerates, while coverage also cited a Senate breakup bill. The prospect of structural changes adds policy uncertainty for UnitedHealth and contributed to selling pressure. Read article
  • Negative Sentiment: UnitedHealth’s weakness also weighed on healthcare funds with significant exposure to the company, potentially amplifying the impact of the stock’s decline. Read article

UnitedHealth Group Stock Down 5.5%

Shares of UnitedHealth Group stock opened at $389.45 on Wednesday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The company has a market cap of $348.96 billion, a price-to-earnings ratio of 22.24, a price-to-earnings-growth ratio of 1.49 and a beta of 0.51. The company’s 50 day moving average is $391.42 and its 200 day moving average is $366.73.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. The company had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. UnitedHealth Group’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be given a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s payout ratio is presently 53.00%.

Wall Street Analyst Weigh In

UNH has been the topic of several research reports. TD Cowen restated a “hold” rating and set a $402.00 price objective on shares of UnitedHealth Group in a research report on Thursday, October 15th. DA Davidson set a $512.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Royal Bank Of Canada raised their price target on UnitedHealth Group from $478.00 to $498.00 and gave the company an “outperform” rating in a research report on Tuesday, October 20th. Mizuho lifted their price target on UnitedHealth Group from $493.00 to $500.00 and gave the stock an “outperform” rating in a research note on Thursday, October 22nd. Finally, Piper Sandler upped their price objective on UnitedHealth Group from $502.00 to $504.00 and gave the stock an “overweight” rating in a report on Wednesday, October 14th. Twenty investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $463.93.

Get Our Latest Research Report on UnitedHealth Group

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.19% of the company’s stock.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.